Transforming growth factor-β1 release from oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment

Journal of Controlled Release

Volumn 94, Issue 1, 2004, Pages 101-114

  Holland, Theresa A ^a   Tessmar, Joerg K V ^a   Tabata, Yasuhiko ^b   Mikos, Antonios G ^a  

^a Rice University   (United States)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Cartilage tissue engineering; Controlled growth factor delivery; Degradable hydrogel; Enzymatic degradation; Gelatin microparticles

Indexed keywords

BIODEGRADATION; BIOPOLYMERS; CROSSLINKING; ENZYME KINETICS; GROWTH KINETICS; HYDROGELS; OLIGOMERS; PH EFFECTS; SWELLING;

GROWTH FACTOR; MICROPARTICLES;

DRUG DOSAGE;

COLLAGENASE; DRUG VEHICLE; ETHYLENE GLYCOL DERIVATIVE; GLUTARALDEHYDE; OLIGOPOLYETHYLENE GLYCOL FUMARATE; POLYMER; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ACIDITY; ARTICLE; CARTILAGE DEGENERATION; COMPLEX FORMATION; CONTROLLED DRUG RELEASE; CROSS LINKING; DIFFUSION; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; GEL PERMEATION CHROMATOGRAPHY; HYDROGEL; PH MEASUREMENT; PRIORITY JOURNAL; WOUND HEALING;

EID: 0347365762     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2003.09.007     Document Type: Article

References (26)

1. LeBaron R.G., Athanasiou K.A. Ex vivo synthesis of articular cartilage. Biomaterials. 21:2000;2575-2587.
2. Hunziker E.B. Articular cartilage repair: are the intrinsic biological constraints undermining this process insuperable? Osteoarthr. Cartil. 7:1999;15-28.
3. Gillogly S.D., Voight M., Blackburn T. Treatment of articular cartilage defects of the knee with autologous chondrocyte implantation. J. Orthop. Sports Phys. Ther. 28:1998;241-251.
4. Silver F.H., Glasgold A.I. Cartilage wound healing. An overview. Otolaryngol. Clin. North Am. 28:1995;847-864.
5. Fisher J.P., Vehof J.W.M., Dean D., van der Waerden J.P., Holland T.A., Mikos A.G., Jansen J.A. Soft and hard tissue response to photocrosslinked poly(propylene fumarate) scaffolds in a rabbit model. J. Biomed. Mater. Res. 59:2002;547-556.
6. Shin H., Ruhe P.Q., Mikos A.G., Jansen J.A. In vivo bone and soft tissue response to injectable biodegradable oligo(poly(ethylene glycol) fumarate) hydrogels. Biomaterials. 24:2003;3201-3211.
7. Holland T.A., Tabata Y., Mikos A.G. In vitro release of transforming growth factor-beta1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels. J. Control. Release. 91:2003;299-313.
8. Nimni M.E. Polypeptide growth factors: targeted delivery systems. Biomaterials. 18:1997;1201-1225.
9. Hollinger J.O., Leong K. Poly(alpha-hydroxy acids): carriers for bone morphogenetic proteins. Biomaterials. 17:1996;187-194.
10. Holland T.A., Mikos A.G. Advances in drug delivery for articular cartilage. J. Control. Release. 86:2003;1-14.
11. Nguyen Q., Murphy G., Hughes C.E., Mort J.S., Roughley P.J. Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein. Biochem. J. 295(Pt. 2):1993;595-598.
12. Martel-Pelletier J., McCollum R., Fujimoto N., Obata K., Cloutier J.M., Pelletier J.P. Excess of metalloproteases over tissue inhibitor of metalloproteases may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab. Invest. 70:1994;807-815.
13. Clark I.M., Murphy G. Matrix proteinases. Seibel M.J., Robins S.P., Bilezikian J.P. Dynamics of Bone and Cartilage Metabolism. 1999;137-150 Academic Press, New York.
14. Lu L., Stamatas G.N., Mikos A.G. Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles. J. Biomed. Mater. Res. 50:2000;440-451.
15. Yoshihara Y., Nakamura H., Obata K., Yamada H., Hayakawa T., Fujikawa K., Okada Y. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann. Rheum. Dis. 59:2000;455-461.
16. Haralson M., Hassell J. Extracellular Matrix: A Pratical Approach. 1995;IRL Press, Oxford University Press.
17. Tabata Y., Hijikata S., Muniruzzaman M., Ikada Y. Neovascularization effect of biodegradable gelatin microspheres incorporating basic fibroblast growth factor. J. Biomater. Sci., Polym. Ed. 10:1999;79-94.
18. Hong L., Tabata Y., Miyamoto S., Yamada K., Aoyama I., Tamura M., Hashimoto N., Ikada Y. Promoted bone healing at a rabbit skull gap between autologous bone fragment and the surrounding intact bone with biodegradable microspheres containing transforming growth factor-beta1. Tissue Eng. 6:2000;331-340.
19. Yamamoto M., Ikada Y., Tabata Y. Controlled release of growth factors based on biodegradation of gelatin hydrogel. J. Biomater. Sci., Polym. Ed. 12:2001;77-88.
20. Hunziker E.B., Driesang I.M., Saager C. Structural barrier principle for growth factor-based articular cartilage repair. Clin. Orthop. 2001;S182-S189.
21. Hunziker E.B., Driesang I.M., Morris E.A. Chondrogenesis in cartilage repair is induced by members of the transforming growth factor-beta superfamily. Clin. Orthop. 2001;S171-S181.
22. Jo S., Shin H., Shung A.K., Fisher J.P., Mikos A.G. Synthesis and characterization of oligo(poly(ethylene glycol) fumarate) macromer. Macromolecules. 34:2001;2839-2844.
23. Neter J., Wasserman W., Kutner M.H. Applied Linear Statistical Models. 1985;Richard D. Irwin, Homewood, IL.
24. Temenoff J.S., Athanasiou K.A., LeBaron R.G., Mikos A.G. Effect of poly(ethylene glycol) molecular weight on tensile and swelling properties of oligo(poly(ethylene glycol) fumarate) hydrogels for cartilage tissue engineering. J. Biomed. Mater. Res. 59:2002;429-437.
25. Solchaga L.A., Dennis J.E., Goldberg V.M., Caplan A.I. Hyaluronic acid-based polymers as cell carriers for tissue-engineered repair of bone and cartilage. J. Orthop. Res. 17:1999;205-213.
26. Bryant S.J., Anseth K.S. Controlling the spatial distribution of ECM components in degradable PEG hydrogels for tissue engineering cartilage. J. Biomed. Mater. Res. 64A:2003;70-79.